Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
Clinical trial NCT00004930 · COMPLETED
Trial details
- NCT number
- NCT00004930
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2004-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.